6505--Cefuroxime Tablets (VA-26-00005794)

The Department of Veterans Affairs National Acquisition Center is procuring Cefuroxime Axetil Tablets through this solicitation to establish a pharmaceutical supply contract for multiple federal agencies. The procurement covers four line items of Cefuroxime Axetil Tablets in 250mg and 500mg strengths, with package sizes of 20 and 60 tablets per bottle, to serve the VA, Department of Defense, Bureau of Prisons, and Indian Health Service facilities. Manufacturers must provide unique NDC numbers, comply with FDA current Good Manufacturing Practice standards, and meet Drug Supply Chain Security Act requirements. Offerors are required to submit pricing for all line items and option years, with prices including a 0.5% Cost Recovery Fee. The solicitation closes on October 8, 2025 at 2:30 PM, with an anticipated contract award date of September 24, 2025.

This procurement is designated as a small business set-aside with a size standard of 1,300 employees, indicating no other set-aside categories apply. The contract structure includes a base year followed by four one-year option periods, providing up to five years of pharmaceutical supply services. Distribution will occur through Pharmaceutical Prime Vendor programs, with McKesson Corporation specifically identified as one of the prime vendors involved in the distribution network. The solicitation requires pricing submissions for estimated annual usage quantities across all participating federal agencies and facilities. Performance will involve manufacturing and supplying pharmaceutical products to support the healthcare needs of veterans, military personnel, federal prisoners, and Native American populations served by these agencies.